Stentys Updates on Sirolimus-Eluting Stent Study HispanicBusiness.com Stentys , a medical technology company commercializing in Europe the Self-Apposing Stent to treat acute myocardial infarction, announced results from the four-month arm of the Apposition IV study of its new Self-Apposing Sirolimus-eluting stent during ... |
